Heat-shock protein 90 inhibitors as antitumor agents: a survey of the literature from 2005 to 2010
Author:
Publisher
Informa Healthcare
Subject
Drug Discovery,Pharmacology,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/13543776.2011.594041
Reference111 articles.
1. Altered states: selectively drugging the Hsp90 cancer chaperone
2. Hsp90: the vulnerable chaperone
3. Inhibition of Hsp90: a new strategy for inhibiting protein kinases
4. Targeting multiple signal transduction pathways through inhibition of Hsp90
5. Hsp90 inhibitors as novel cancer chemotherapeutic agents
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. An update on the status of HSP90 inhibitors in cancer clinical trials;Cell Stress and Chaperones;2024-08
2. Detailed curriculum vitae of HER2-targeted therapy;Pharmacology & Therapeutics;2023-05
3. Small-Molecule Inhibitors of Protein–Protein Interactions as Therapeutics;Protein-Protein Interactions;2023
4. Synthesis and Biological Activity of 3-(Heteroaryl)quinolin-2(1H)-ones Bis-Heterocycles as Potential Inhibitors of the Protein Folding Machinery Hsp90;Molecules;2022-01-09
5. Does HSP90 play an important role in psoriasis?;Advances in Dermatology and Allergology;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3